LASA

Lasa Supergenerics Ltd.

NSE: LASA

BSE: 540702

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

5.36+0.0 (+0.00%)

9 Oct, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

28.19

P/E (TTM)

P/B

0.57

P/S (TTM)

4.44

EV/EBITDA

CAPE (5Y)

ROE (TTM)

-51.13

ROCE (TTM)

-18.43

ROA (TTM)

-40.63

Avg 3Y ROE

-29.24

Earnings 3Y CAGR

21.48

Sales 3Y CAGR

-63.55

Sales 5Y CAGR

-48.98

Debt/Equity

0.20

Consensus TP

Strong Buy %

Promoter Holding

Pledged %

Stock Analysis

Fundamental analysis overview of Lasa Supergenerics Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 52.57% for 12-month ended 30 Jun 2026 and the growth was 45.12 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.2 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.17 in the last 1 year

What is Debt to Equity?

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -58.7% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low and declining ROE

The company reported low ROE of -51.13% for 12-month ended 30 Jun 2026 and ROE declined by -3477 bps from 1 year ago

What is ROE (FY)?

Low and declining operating margin

The company reported low operating margin of -224.5% for 12-month ended 30 Jun 2026 and operating margin declined by -21910 bps from 1 year ago

What is Operating profit margin?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of -95.17% for 12-month ended 30 Jun 2026 and the growth was 105.85 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 10.68

Value -95.17

-99.6111701.8

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Not enough talking points with neutral stance

Financial Snapshot

See detailed analysis

Multi-year trends for Lasa Supergenerics Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Lasa Supergenerics Ltd. Shareholding Pattern

Quarterly breakdown of Lasa Supergenerics Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	64.47	64.47	64.47	64.47	64.47	64.47	64.47	45.01	43.78	43.78	43.78	43.78	53.65	53.65	53.65	53.65	53.65	53.65	53.65	53.65	53.65	53.65	53.65	53.65	53.65
Indian Promoter	64.47	64.47	64.47	64.47	64.47	64.47	64.47	45.01	43.78	43.78	43.78	43.78	53.65	53.65	53.65	53.65	53.65	53.65	53.65	53.65	53.65	53.65	53.65	53.65	53.65
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.00	-	-	-	-	0.02	0.01	0.06	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.01	0.12	0.00	0.01	0.00	0.00	0.47	-	-	-
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.02	0.01	0.06	0.00	0.40	0.00	0.00	0.00	0.00	0.00	0.01	0.12	0.00	0.01	0.00	0.00	0.47	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	35.53	35.53	35.53	35.53	35.53	35.51	35.52	54.93	56.21	55.82	56.22	56.22	46.35	46.35	46.34	46.34	46.23	46.35	46.34	46.35	46.35	45.88	46.35	46.35	46.35
Bodies Corporate	1.16	0.97	3.44	-	3.44	0.79	1.11	1.34	1.04	1.16	15.09	1.20	0.89	0.79	9.30	0.86	0.98	0.95	1.08	1.06	1.04	0.94	0.90	0.91	0.89
Others (incl. Retail) No. of shareholders	34.37 17,118	34.56 17,682	32.09 18,850	35.53 19,206	32.09 19,024	34.72 21,932	34.41 22,948	53.59 24,705	55.17 27,735	54.66 29,948	41.13 29,544	55.02 28,798	45.46 28,687	45.56 27,910	37.04 27,659	45.48 27,053	45.25 27,511	45.40 27,114	45.26 27,871	45.29 27,174	45.31 27,090	44.94 28,015	45.45 28,557	45.44 28,024	45.46 27,607

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Lasa Supergenerics Ltd. is not part of any tracked index.

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Lasa Supergenerics Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Vineeta Hitesh Wadhwani Connected Person	April-2023	Market Sale (Disposal) 5th Apr 2023	0.30 %	₹ 22.00	58.50 k	₹ 12.87 lac

Corporate Actions

History of Lasa Supergenerics Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.25/share
Record date: 19th Sep 2022Ex-date: 16th Sep 2022
Announced on: 11th Apr 2022
Dividend₹ 0.25/share
Record date: 16th Sep 2021Ex-date: 15th Sep 2021
Announced on: 31st May 2021

Company Profile

Overview of Lasa Supergenerics Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Lasa Supergenerics Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (API) bulk drugs products. The Company is engaged in the business of manufacturing, trading, producing, processing, preparing, and treating chemicals, API, pharma...

Key personnel

Mrs. Varsha Pravin Joshi

Chief Financial Officer

Mrs. Mitti Jain

Compliance Officer, Company Secretary

Dr. Omkar Pravin HerlekarD

Chairman of the Board, Managing Director

Mr. Prathamesh ChalkeD

Whole Time Director

Mr. Pravin Gadalya LachakeD

Non-Executive Independent Director

Mr. Ketan Bhau SongalD

Non-Executive Independent Director

Mr. Yogesh Hari UghadaD

Non-Executive Independent Director

Mrs. Rekha Hemant WakhD

Non-Executive Independent Director

View all

Incorporated on

11 Mar 2016

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

21 Sep 2017

Free Float

2,27,20,576

Website

https://lasalabs.com/

Phone no.

+912145232101

Address

Office No. 506 & 507,5th floor, Midas, Sahar Plaza, Andheri kurla road, Andheri East, MUMBAI, 400059, India

Frequently Asked Questions

What is the current share price of Lasa Supergenerics Ltd.?

The current share price of Lasa Supergenerics Ltd. is ₹ 5.36 as of 9 Oct 2026.

What is the market capitalisation of Lasa Supergenerics Ltd.?

The market capitalisation of Lasa Supergenerics Ltd. stands at ₹ 28.19 Cr.

What is the PE ratio of Lasa Supergenerics Ltd.?

The Price-to-Earnings (PE) ratio of Lasa Supergenerics Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Lasa Supergenerics Ltd.?

Lasa Supergenerics Ltd. has a Return on Equity (ROE) of -51.13% and a Return on Capital Employed (ROCE) of -18.43% as per the latest financial reports.

What is the 52-week high and low of Lasa Supergenerics Ltd.?

The 52-week high of Lasa Supergenerics Ltd. is - and the 52-week low is -.

What is the dividend yield of Lasa Supergenerics Ltd.?

The dividend yield of Lasa Supergenerics Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Lasa Supergenerics Ltd.?

Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of Lasa Supergenerics Ltd. shares.

What sector does Lasa Supergenerics Ltd. belong to?

Lasa Supergenerics Ltd. operates in the Healthcare sector.

What is the beta of Lasa Supergenerics Ltd.?

The beta of Lasa Supergenerics Ltd. is 0.65, indicating its price volatility relative to the broader market. Over the past 1 year, Lasa Supergenerics Ltd. has delivered an absolute return of -54.81%.

What is the RSI of Lasa Supergenerics Ltd.?

The 14-day Relative Strength Index (RSI) of Lasa Supergenerics Ltd. is 18.14, placing it in the oversold zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Lasa Supergenerics Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Lasa Supergenerics Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile

Holdings and Presence

Corporate Actions